Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czechia
Cyprus
Denmark
Estonia
Germany
Hungary
Italy
Kosowo
Latvia
Lithuania
Luxembourg
Macedonia
Montenegro
Poland
Portugal
Romania
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
United Kingdom
Hong Kong
Kuwait
Lebanon
UAE
RSA
Vita 34 returns to growth path in 2023
EQS-News: Vita 34 AG / Key word(s): Annual ResultsVita 34 returns to growth path in 2023 30.04.2024 /
Read more
Investor News
Go to section:
-
-
Vita 34 downsizes Management Board until further notice EQS-News: Vita 34 AG / Key word(s): PersonnelVita 34 downsizes Management Board until further notice Read more
-
Vita 34 increases revenue and earnings in Q3 2023 and further stabilizes business development EQS-News: Vita 34 AG / Key word(s): Quarter ResultsVita 34 increases revenue and earnings in Q3 2023 Read more
-
Vita 34 stabilizes business development in the second quarter and noticeably improves earnings EQS-News: Vita 34 AG / Key word(s): Half Year ResultsVita 34 stabilizes business development in the second Read more
-
Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment EQS-News: Vita 34 AG / Key word(s): Quarter ResultsVita 34 successfully implements price increases in Read more
-
Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate EQS-News: Vita 34 AG / Key word(s): StudyVita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Read more
Registration for our Email Service
You can register to be on the distribution list for our IR news with the following contact form in order to receive our latest publications and other notifications.